Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commissioner Must Not Come From Agency, Stupak Advises Obama

This article was originally published in The Tan Sheet

Executive Summary

Rep. Bart Stupak has called on the incoming administration to look outside FDA for the next commissioner - even to fill the post short-term on an acting basis
Advertisement

Related Content

Public Citizen's FDA? Lurie Is Consumer Group's Third In Key Agency Role
Lurie Moves To FDA, Becomes Third Public Citizen Staffer With Key Role
Lurie Moves To FDA, Becomes Third Public Citizen Staffer With Key Role
Public Citizen's FDA? Lurie Is Consumer Group's Third To Play Key Role At Agency
Von Eschenbach Resigning In January With BTC Debate In His Legacy
Congress Presses FDA To Speak Up On OTC/Supplement Combo Products
Election 2008: Both Candidates Are Likely To Change FDA’s Direction
Congressional Critics Offer Two Approaches To Drug Safety Responsibility
Congressional Critics Offer Two Approaches To Drug Safety Responsibility
Supreme Court Ties On FDA Pre-Emption; Congress Seeks To Resolve Issue

Topics

Advertisement
UsernamePublicRestriction

Register

PS102377

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel